Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113045445A details a cost-effective route for SNAC precursors. Discover high-purity pharmaceutical intermediates and scalable manufacturing solutions.
Novel patent CN105693496B enables mild synthesis of high-purity stable isotope labeled intermediates. Offers significant supply chain reliability and cost reduction for pharmaceutical manufacturing.
Patent CN102731478A details a high-yield asymmetric oxidation route for Dexlansoprazole intermediates, offering superior optical purity and scalable manufacturing capabilities for global supply chains.
Patent CN120535435A reveals a safer two-phase synthesis for crisaborole intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN1759097A details a safer process for PDF inhibitor intermediates using specific beta-lactams and selective debenzylation, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN103467282A details a mild, iridium-catalyzed visible light method for synthesizing polysubstituted naphthols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN101824052A details a mild NHC-metal complex catalyzed method for phosphine synthesis, offering cost reduction in fine chemical manufacturing and high-purity ligand production.
Patent CN104507922B details a novel enantioselective process for chromen-4-one derivatives, offering high purity and scalable solutions for pharmaceutical intermediate supply chains.
Patent CN106543054A reveals novel pleuromutilin synthesis. Enhances supply chain reliability and cost reduction in antibiotic manufacturing for global partners.
Patent CN102491915B details a high-yield hydrolysis method for ubenimex intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN102010341A reveals Ni-B catalyst method for 4-aminodiphenylamine reducing costs and waste significantly for reliable supply chain partners.
Novel non-halide process for 4-ADPA derivatives offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN108101946B details a continuous flow method for producing high-purity 2,3,4,6-tetra-O-benzyl-D-glucose, offering significant yield improvements and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN118063351B reveals immobilized enzyme process for high-purity chiral beta-amino acids, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Advanced catalytic route for Nateglinide production offering cost reduction in API manufacturing and enhanced supply chain reliability for global pharmaceutical partners.
Patent CN115109041A reveals a novel synthetic route for Encetavir intermediates, offering higher yields and simplified purification for reliable pharmaceutical supply chains.
Patent CN106083546A details a high-yield Grignard method for 3,5-dibromo benzaldehyde, ensuring supply chain stability and cost reduction in electronic chemical manufacturing.
Novel antibacterial synthesis via cyclization. Cost-effective, scalable route for agrochemical intermediates ensuring supply continuity.
Patent CN111479795A details a high-yield process for dialkyl ethers using metallic sodium and monoether-monoalcohol catalysts, offering significant cost and safety advantages.
Patent CN114276306A reveals a novel sulfentrazone synthesis route improving yield and purity by performing nitration before triazolinone ring formation.